TAS-102 in Patients With Advanced, Refractory Pancreatic Adenocarcinoma

Clinical trial NCT04923529 · COMPLETED

Trial details

NCT number: NCT04923529
Sponsor: The University of Hong Kong
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pancreas Cancer

Start date: 2021-03-01
Primary completion: 2024-03-25
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.